NCT03441477

Brief Summary

The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device. The secondary objective is to demonstrate that the test device is as safe as the predicate devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 16, 2019

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

February 11, 2022

Completed
Last Updated

July 3, 2023

Status Verified

January 1, 2022

Enrollment Period

1.1 years

First QC Date

January 17, 2018

Results QC Date

December 13, 2021

Last Update Submit

June 29, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Agreement of Intraocular Pressure

    Agreement of the measured IOP between the test device and the predicate device for the tonometer function of NIDEK TONOREF III. The mean difference and the standard deviation between these two devices are shown in the outcome measures table.

    1 day

  • Agreement of Corneal Thickness

    Agreement of the measured corneal thickness between the test device and the predicate device for the pachymeter function of the NIDEK TONOREF III. The mean difference and the standard deviation between these two devices are shown in the outcome measure table.

    1 day

Secondary Outcomes (1)

  • Number of Occurrences of Adverse Events

    1day

Study Arms (1)

Adults 18 years old or older

EXPERIMENTAL

Nidek Tonoref III

Device: Nidek Tonoref IIIDevice: Haag-Streit Goldmann Manual TonometerDevice: NIDEK CEM-530

Interventions

The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye.

Adults 18 years old or older

Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma

Adults 18 years old or older

Nidek CEM-530 is a non-contact ophthalmic microscope, optical pachymeter, and camera used for examination of the corneal endothelium and for measurement of the thickness of the cornea.

Adults 18 years old or older

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be at least 18 years of age of either sex and any race or ethnicity;
  • be willing and able to provide written informed consent prior to any study procedures being performed;
  • be willing and able to follow all instructions and attend all study visits;

You may not qualify if:

  • have only one functional eye;
  • have poor or eccentric fixation in either eye;
  • have corneal scarring or have had corneal surgery, including corneal laser surgery in either eye;
  • have microphthalmos in either eye;
  • have buphthalmos in either eye;
  • be a contact lens wearer, meaning having worn soft contact lenses within the past 3 months and/or rigid permeable gas lenses within the past 6 months;
  • have dry eyes, meaning having been diagnosed by a physician with dry eyes and currently using a prescribed medication or daily use of artificial tears;
  • be a lid squeezer - blepharospasm;
  • have nystagmus in either eye;
  • have keratoconus in either eye;
  • have any other corneal or conjunctival pathology or infection in either eye;
  • have a condition or a situation, which in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andover Eye Associates

Andover, Massachusetts, 01810, United States

Location

Results Point of Contact

Title
Tadakazu Ichimura
Organization
NIDEK Co., LTD.

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2018

First Posted

February 22, 2018

Study Start

December 17, 2017

Primary Completion

January 16, 2019

Study Completion

January 16, 2019

Last Updated

July 3, 2023

Results First Posted

February 11, 2022

Record last verified: 2022-01

Locations